NCT04431908 Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects Status COMPLETED Phase N/A
NCT04431453 Study of Remdesivir in Participants Below 18 Years Old With COVID-19 Status COMPLETED Phase PHASE2/PHASE3
NCT04431310 Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic Status UNKNOWN Phase N/A
NCT04430608 Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients Status COMPLETED Phase NA
NCT04430049 Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients Status COMPLETED Phase N/A
NCT04429867 Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease Status UNKNOWN Phase PHASE4
NCT04429763 Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia Status UNKNOWN Phase PHASE2
NCT04429711 Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19 Status UNKNOWN Phase NA
NCT04428801 Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19 Status NOT_YET_RECRUITING Phase PHASE2
NCT04428021 Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure Status COMPLETED Phase PHASE2
NCT04428008 Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients Status COMPLETED Phase PHASE2
NCT04427865 Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19 Status UNKNOWN Phase PHASE2/PHASE3
NCT04427566 Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise Status TERMINATED Phase PHASE2
NCT04427501 A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness Status COMPLETED Phase PHASE2/PHASE3
NCT04427358 RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population Status COMPLETED Phase N/A
NCT04427098 Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients Status COMPLETED Phase PHASE2
NCT04426695 Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19 Status COMPLETED Phase PHASE1/PHASE2